Skip to main content

 

GORE® VIATORR® TIPS Endoprosthesis with Controlled Expansion

Catalogue Number 

Selection range for

internal diameter (mm) a

Graft-lined 

length (cm) b

Unlined 

length (cm) b

Guidewire 

diameter (in) c

Introducer 

sheath size (Fr) d

Maximum 

dilatation balloon 

diameter (mm) a

PTB61042756–10 420.0351010
PTB61052756–10520.0351010
PTB61062756–10620.0351010
PTB61072756–10720.0351010
PTB61082756–10820.0351010

 

GORE® VIATORR® TIPS Endoprosthesis with Controlled Expansion

Catalogue Number 

Selection range for

internal diameter (mm) a

Graft-lined 

length (cm) b

Unlined 

length (cm) b

Guidewire 

diameter (in) c

Introducer 

sheath size (Fr) d

Maximum 

dilatation balloon 

diameter (mm) a

PTB81042758–10 420.0351010
PTB81052758–10520.0351010
PTB81062758–10620.0351010
PTB81072758–10720.0351010
PTB81082758–10820.0351010

a The selected balloon diameter may be 6, 7, 8, 9, or 10 mm, and should not exceed 10 mm. A balloon which can reach an inflation pressure of 10 ATM must be selected, and should be inflated to a minimum of 10 ATM.  
b Lengths may vary by ± 0.5 cm. 
c A stiff guidewire, having a length of at least 180 cm and a diameter as listed in the table, is required. Delivery catheter working length is 75 cm for all endoprosthesis configurations. 
d Introducer sheath length must be sufficient to be delivered into the portal circulation by ≥ 3 cm. It is recommended that a wall-reinforced 10 Fr TIPS introducer sheath with an integral radiopaque marker band, a hemostatic valve large enough to accept the 13 Fr access sleeve, and a length of approximately 40-45 cm be used (e.g., GORE® TIPS Sheath or COOK® FLEXOR® CHECK-FLO® II).

Sizing, availability and pricing varies by country.

Please check with your Gore representative for availability. 

IFU Consult instructions

Refer to Instructions for Use at eifu.goremedical.com ffor a complete description of all applicable indications, warnings, precautions and contraindications for the markets where this product is available. RXOnly

INDICATIONS FOR USE IN THE U.S.: The GORE® VIATORR® TIPS Endoprosthesis is indicated for use in the de novo and revision treatment of portal hypertension and its complications such as variceal bleeding, gastropathy, ascites which recurs despite conventional treatment, and/or hepatic hydrothorax.

INDICATIONS FOR USE IN CANADA: The GORE® VIATORR® TIPS Endoprosthesis with Controlled Expansion is indicated for use in the treatment of portal hypertension and its complications such as variceal bleeding and ascites which recurs despite conventional treatment.

CONTRAINDICATIONS: There are no known contraindications for this device.